NanoSpun Technologies, a pioneer and a global frontrunner company in the spaces of biotech, advanced materials and bioprinting, is concluding $5 million in equity round of financing. This is another important milestone in NanoSpun progress and growth strategy.

The new funding will be used to further develop and commercialize its promising live and active skincare facemasks and “Probiotic Second Skin” tissues which improve and modulate skin’s health for better beauty and skincare results. The new investment round will also enable NanoSpun to scaleup its production capacity, grow its team and take the company to the next commercial phase including launching of NanoSpun Skincare products in the second half of 2022. In addition, NanoSpun will utilize the round of financing proceeds to further develop the Company’s proprietary “Biology as Cassette” bioprocessing products and solutions, a novel and groundbreaking innovation for the rapidly growing bioproduction, fermentation, and perfusion markets.

Based on the company proprietary disruptive technology, NanoSpun is leading the way with game-changing innovative products and solutions that opens the door for a new generation of cells-based products and processes and transforming biological products and processes into a tangible, efficient and effective reality.